Ex Vivo Remodeling of Excised Blood Vessels for Vascular Grafts

Abstract

The present invention provides an ex vivo vascular remodeling methods and system by which an excised, small diameter blood vessel can be harvested and expanded to provide viable vascular grafts, as demonstrated at the physical and molecular levels, and as optimized in vivo. The tissue-engineered vessels generated by the present invention closely resemble native vessels in terms of structure, histologically, including endothelial coverage and intricate structural components such as the internal elastic lamina, viability (as measured with MTT assay and TUNEL analysis), and function (vasoactivity, mechanical and biomechanical properties). Thus, the resulting vascular grafts behave in a manner similar to native arteries in terms of mechanical integrity, and provide clinically relevant patency rates when implanted in vivo. Moreover, the ex vivo methods and system permit the precise control of the mechanical environment involving the excised vessel, while at the same time permitting carefully monitoring of the resulting growth / remodeling, thereby opening new avenues of research regarding the mechanical stimuli responsible for specific aspects of remodeling in vivo.

Description

REFERENCE TO RELATED APPLICATIONS[0001]This application is a Divisional of application Ser. No. 11 / 273,888, filed Nov. 14, 2005, which is a Continuation of application Ser. No. 10 / 165,461, filed Jun. 7, 2002, which in turn claims priority to Provisional Application 60 / 297,203, filed Jun. 8, 2001, each of which are herein incorporated in their entirety.GOVERNMENT INTERESTS[0002]This invention was supported in part by the National Institutes of Health Grant No. R01HL64388-01A1. The Government may have certain rights in this invention.FIELD OF THE INVENTION[0003]This invention relates generally to the field of tissue remodeling, specifically the ex vivo remodeling of blood vessels for use as vascular grafts.BACKGROUND OF THE INVENTION[0004]More than a century ago, based on observations of the microvasculature, Thoma proposed that longitudinal tension controls vessel length. Since then, a number of studies have shown that blood vessels can remodel either physiologically or pathologicall...

AI Technical Summary

Benefits of technology

[0019]The present invention provides a system and method by which a small blood vessel is harvested without morbidity of the donor, and the diameter, length, and wall thickness of the excised vessel are increased by subjecting the vessel to the appropriate mechanical environment ex vivo over time. Thus, a tissue-engineered vessel is produced, which is suitable for use as a blood vessel graft in vivo.

[0021]In addition, the system allows for the control of several key aspects of the mechanical environment. It is an advantage of this system over the prior art to offer improved control of the mechanical environment and allow real time monitoring of vessel remodeling. An understanding of which mechanical stimuli control vascular remodeling is utilized to rationally direct the remodeling of vessels ex vivo.

[0025]Thus, it is an object of this invention to provide a system and method by which small blood vessels, such as arteries, or even veins, can be harvested with minimal donor site morbidity and remodeled ex vivo, thereby engineering blood vessels for autologous small-caliber vascular grafts. In addition, the ex vivo system is advantageously applied to better understand the molecular biology of vascular remodeling by facilitating the testing of hypotheses not amenable to study using in vivo or cell culture models.

Problems solved by technology

Clinical observations and animal studies indicate that vessels remodel in response to altered mechanical environments, but the complex interdependence between components of the mechanical environment (e.g., pressure, shear, and strain) in vivo has hindered the identification of the specific mechanical stimuli responsible for specific aspects of remodeling.

Images